Panakeia

Pahini holds a PhD from King’s College London in Cell and Molecular Biophysics. Her research took her into the failure of protease inhibitors as potential therapeutic agents for cancer. Prior to cofounding Panakeia, Pahini was a Research Associate at Cambridge University. She is also currently part of the Global Shapers Community (an initiative of the World Economic Forum), a network of Hubs developed and led by young people who are exceptional in their potential, achievements, and drive to make a contribution to their communities.

Pandu has eight years of award winning expertise in machine learning, computational biology, mathematical modelling as well as cancer drug discovery and design. He managed research projects and products within major organisations (including Siemens, Roche, Vodafone) as well as publications of state-of-the-art methods in biomedical image analysis and genomics. Pandu holds degrees in Bioinformatics, Computer Science and Mathematics from ETH Zurich, LMU Munich, the Technical University of Munich, and Cambridge University.